Press Releases on November 12, 2024 - EIN Presswire - Press Release Distribution Service

Published on November 12, 2024 - 21:01 GMT

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic …

Distribution channels: Technology ...

Published on November 12, 2024 - 21:01 GMT

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 Total revenues for the third quarter ended September 30, …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm Adding FT819 to Maintenance Therapy without Conditioning Chemotherapy Opened for Enrollment FT522 Multi-indication …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Voyager Reports Third Quarter 2024 Financial and Operating Results

- Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer’s; on track to generate top-line data H1 2025 - - Recent third-party clinical data establish that an antibody can inhibit tau accumulation in …

Distribution channels: Business & Economy, Technology ...

Published on November 12, 2024 - 21:01 GMT

Erasca Reports Third Quarter 2024 Business Updates and Financial Results

Positive preliminary Phase 1b data in SEACRAFT-1 NRASm melanoma cohort bolsters conviction in ongoing SEACRAFT-2 registrational trial; Stage 1 randomized data expected in 2025 Strong execution across potentially best-in-class RAS targeting franchise; …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12: …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing Cohort Interim Data from Atopic Dermatitis Trial Expected to be Announced December 2024 Registration Phase 3 Clinical Trial of Soquelitinib in Peripheral T Cell …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Xenon Reports Q3 2024 Financial Results and Business Update

– Phase 3 epilepsy program advancing with X-TOLE2 topline FOS data anticipated in H2 2025 – Long-term azetukalner results from X-TOLE open-label extension study in FOS to be presented at AES – Phase 3 MDD program on track with X-NOVA2 study expected to …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Presented compelling new preclinical data demonstrating anti-tumor activity for OP-3136, a novel KAT6 inhibitor, with enhanced activity of palazestrant combinations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024) New …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2024 - 21:01 GMT

Alliance Entertainment Reports First Quarter Fiscal Year 2025 Results

Operational efficiencies drove improved profitability Strengthened balance sheet including 33% reduction in revolver debt Higher-margin Direct to Consumer sales increased to 34% of gross revenue PLANTATION, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alliance …

Distribution channels: Business & Economy, Retail ...

Published on November 12, 2024 - 21:01 GMT

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

CANTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2024 - 21:01 GMT

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Announced positive initial data from first three subjects with type 1 diabetes …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted share Entered into an asset purchase agreement to acquire Increlex® (mecasermin injection) Q3 2024 product sales increased 40% over Q3 2023, representing 15th …

Distribution channels:

Published on November 12, 2024 - 21:01 GMT

ElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech Award

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness product, Truvaga Plus, has been awarded the prestigious Men’ …

Distribution channels:

Published on November 12, 2024 - 21:00 GMT

Jason Owen Launches Into The Christmas Spirit With ‘All I Want For Christmas Is You’

Jason Owen returns with his country rock version of the classic ‘All I Want For Christmas Is You’ just in time for the festive season. NEW SOUTH WALES, AUSTRALIA, November 13, 2024 /⁨EINPresswire.com⁩/ -- Can you believe that it has been thirty years …

Distribution channels: Movie Industry, Music Industry ...

Published on November 12, 2024 - 21:00 GMT

BMBL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bumble Inc. Investors with Substantial Losses Have ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bumble Inc. (“Bumble” or “the Company”) ( …

Distribution channels: Consumer Goods, Law ...

Published on November 12, 2024 - 21:00 GMT

JBI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Janus International Group, Inc. and ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Janus International Group, Inc. (“Janus” or “the Company”) (NYSE: JBI). Investors who …

Distribution channels: Consumer Goods, Law ...

Published on November 12, 2024 - 21:00 GMT

SUNLQ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sunlight Financial Holdings, Inc. f/k/a Spartan Acquisition ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sunlight Financial Holdings, Inc. f/k/a …

Distribution channels: Consumer Goods, Law ...

Published on November 12, 2024 - 21:00 GMT

FNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Paragon 28, Inc. Investors with Substantial Losses Have ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or “the …

Distribution channels: Consumer Goods, Law ...